Onychodystrophy PCR Testing
Targeted Treatment Starts by Identifying the Exact Infectious Organism
Causative infectious organisms are colorless and invisible to the eye
Laboratory testing provides objective information for precise treatment
Determining the exact infectious agents to treat leads to improved patient outcomes and could save patients time & Rx costs
Complete the form below to get answers to your questions about BakoDx’s Onychodystrophy PCR testing with terbinafine resistance.
Please note: individual reflex test options of certain yeast, pseudomonas aeruginosa and terbinafine resistance mutations are pending availability in NY.
Advantages of the BakoDx Onychodystrophy PCR Test
with Terbinafine Resistance
Detect genus and species for targeted oral and topical antifungal therapy. Quickly determine if terbinafine treatment is likely to be effective.
Assess patient results with high confidence.
99.9% analytical specificity 86% clinical sensitivity;¹ Correlates highly with histopathology.
Save patients time and Rx costs by knowing before you treat. Focus on testing only for relevant agents of disease.
Document the genus and species information needed for pre-authorization of many antifungal prescriptions.
Contracted with all major insurance plans, and over 200 local insurance plans; Covered by Medicare.
Begin appropriate treatment quickly with 1-2 day turnaround time.
The Difference with Our
- Reflexes to secondary testing only when positive to reduce medical costs
- Detects 12 terbinafine resistance mutations in just 4 reactions for cost effectiveness
- Identifies multiple causative organism targets in a single specimen
- Detects low levels of concentration of the causative organism
- Filters out contaminants present in the collected specimen
Educational Resources for Onychodystrophy
¹BakoDx internal validation
Disclaimer: BakoDx, as a partner to your practice, provides learning resources to help you better serve your patients. The information contained within this document should be used at a physician’s discretion. BakoDx assumes no liability for its content..